AvePoint to Participate in June Investor Conferences GlobeNewswire May 15, 2025 JERSEY CITY, N.J., May 15, 2025 (GLOBE NEWSWIRE) — AvePoint (Nasdaq: AVPT), the global leader in data security, governance and resilience, today announced that members of the Company's executive management team will present at the William Blair 45th Annual Growth Stock Conference in Chicago, […]
— Company has continued to advance its previously announced plan to obtain FDA approval for two new drugs and to develop a network of clinics focused on neuroplastic therapies to treat severe and suicidal depression, PTSD, and related conditions. Clinic acquisition financing is at the HOPE Therapeutics level and non-dilutive to NRXP shareholders — In
(NASDAQ:AMAT), Revenue $7.10 billion, up 7 percent year over year GAAP gross margin 49.1 percent and non-GAAP gross margin 49.2 percent GAAP operating margin 30.5 percent and non-GAAP operating margin 30.7 percent Record GAAP EPS $2.63 and record non-GAAP EPS $2.39, up 28 percent and 14 percent year over year, respectively Generated $1.57 billion in
Sempra (NYSE: SRE) today announced that its board of directors has declared a $0.645 per share quarterly dividend on the company's common stock, which is payable July 15, 2025, to common stock shareholders of record at the close of business on June 26, 2025. About SempraSempra is a leading North American energy infrastructure company focused
Bit Digital, Inc. (Nasdaq: BTBT) (the “Company”), a global platform for high-performance computing (“HPC”) infrastructure and digital asset production headquartered in New York City, today announced its financial results for the First Quarter of 2025. The Company will host a conference call on May 16, 2025, at 10:00 AM ET to discuss results (click here
Applied Materials Announces Second Quarter 2025 Results GlobeNewswire May 15, 2025 Revenue $7.10 billion, up 7 percent year over year GAAP gross margin 49.1 percent and non-GAAP gross margin 49.2 percent GAAP operating margin 30.5 percent and non-GAAP operating margin 30.7 percent Record GAAP EPS $2.63 and record non-GAAP EPS $2.39, up 28 percent and
Intermap Announces First Quarter 2025 Results GlobeNewswire May 15, 2025 Company reports first quarter 2025 revenue growth of 153% with 28% pro-forma adjusted EBITDA margin Confirms projected 2025 revenue of $30-35 million and 28% EBITDA margin Conference call today at 5:00 pm ET to discuss results DENVER, May 15, 2025 (GLOBE NEWSWIRE) — Intermap Technologies
(TSX:IMP),(OTC US:ITMSF),(Other OTC:ITMSF), Company reports first quarter 2025 revenue growth of 153% with 28% pro-forma adjusted EBITDA margin Confirms projected 2025 revenue of $30-35 million and 28% EBITDA margin Conference call today at 5:00 pm ET to discuss results DENVER, May 15, 2025 (GLOBE NEWSWIRE) — Intermap Technologies (TSX: IMP; OTCQB: ITMSF) (“Intermap” or the
(NASDAQ:TRIB), DUBLIN, May 15, 2025 (GLOBE NEWSWIRE) — Trinity Biotech plc (Nasdaq: TRIB) a commercial stage biotechnology company focused on diabetes management solutions and human diagnostics, including wearable biosensors, today announced results for the quarter ended December 31, 2024 and the fiscal year then ended. Key Highlights and Developments Management continues to make significant progress
(NASDAQ:OTLK),(NASDAQ:OTLKW), LYTENAVA(TM) (bevacizumab gamma) on track for planned first commercial launches in Germany and the United Kingdom (UK) in Q2 CY2025 Prescription Drug User Fee Act (PDUFA) goal date of August 27, 2025 in the United States ISELIN, N.J., May 15, 2025 (GLOBE NEWSWIRE) — Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company focused on